BCM
TECX

Bridgeway Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Bridgeway Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,383
Closed -$246K – 1295
2025
Q2 		$246K Sell
12,383
-2,285
-16% -$46.3K 0.01% 915
2025
Q1 		$260K Hold
14,668
– – 0.01% 867
2024
Q4 		$677K Sell
14,668
-5,713
-28% -$242K 0.02% 751
2024
Q3 		$618K Buy
20,381
+600
+3% +$11K 0.01% 812
2024
Q2 		$326K Sell
19,781
-2,501
-11% -$40.1K 0.01% 956
2024
Q1 		$342K Buy
22,282
+2,283
+11% +$36.1K 0.01% 1011
2023
Q4 		$326K Buy
19,999
+7,716
+63% +$132K 0.01% 1054
2023
Q3 		$227K Buy
12,283
+3,450
+39% +$61K 0.01% 1073
2023
Q2 		$101K Hold
8,833
– – ﹤0.01% 1253
2023
Q1 		$106K Sell
8,833
-4,167
-32% -$58K ﹤0.01% 1227
2022
Q4 		$111K Hold
13,000
– – ﹤0.01% 1201
2022
Q3 		$100K Buy
13,000
+1,750
+16% +$19.4K ﹤0.01% 1268
2022
Q2 		$124K Sell
11,250
-8,175
-42% -$96.4K ﹤0.01% 1190
2022
Q1 		$308K Buy
19,425
+6,667
+52% +$138K 0.01% 1072
2021
Q4 		$589K Buy
+12,758
New +$733K 0.01% 935

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Bridgeway Capital Management's TECX Position: Q3 2025 in Review

Bridgeway Capital Management sold out of Tectonic Therapeutic (TECX) in Q3 2025, closing a stake of 12,383 shares — an estimated $246K sold.

Bridgeway Capital Management first reported a position in TECX in Q4 2021 and held it in 15 quarters. The position peaked at $677K in Q4 2024. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2025.

  • Bridgeway Capital Management reported no remaining Tectonic Therapeutic position as of Q3 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,383 Tectonic Therapeutic shares in Q3 2025, an estimated $246K.
  • Bridgeway Capital Management first reported a position in Tectonic Therapeutic in Q4 2021 and held it in 15 quarters.
  • Bridgeway Capital Management's Tectonic Therapeutic position peaked at $677K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2025.

Based on Bridgeway Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.